# Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts

> **NCT03158168** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 70 (estimated)

## Conditions studied

- Warts

## Interventions

- **DRUG:** Candida Antigen
- **DRUG:** Zinc Sulfate

## Key facts

- **NCT ID:** NCT03158168
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-01
- **Primary completion:** 2019-06
- **Final completion:** 2019-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2018-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03158168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03158168, "Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03158168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*